Set name | Organism | TF/miRNA | Source | Target-set size | Ref. | Description | |||||||||||||||||||||||||
CREB_Zhang | Human | CREB | CC | 2338 | [29] | Targets of CREB, identified by ChIP-chip in HEK293T cells in three different time points after forskolin stimulation. The microarray covered the promoter region from -700bp to 200bp of 16K genes. | |||||||||||||||||||||||||
E2F4_Cam | E2F | CC | 201 | [5] | Genes that are bound by both E2F4 and p130 in three different growth arrest condtions, identified by ChIP-chip in T98G and U2OS cells under growth arrest. The microarray covered the promoter region from -700bp to 200bp of 13K genes. | ||||||||||||||||||||||||||
E2F_Ren | E2F | CC | 79 | [23] | Targets of E2F4 that are expressed during cell cycle entry, identified by ChIP-chip in quiescent WI-38 cells. The microarray covered the promoter region from -700bp to 200bp of 1444 genes, ~1200 of which show regulated expression during cell cycle reentry. | ||||||||||||||||||||||||||
ERa_Kwon | ESR1 | C-DSL | 496 | [13] | Targets of estrogen receptor α, identified by ChIP-DSL in MCF-7 cells. The array covered the promoter region from -800bp to 200bp of 17K genes. | ||||||||||||||||||||||||||
ETS1_Hollenhorst | ETS1 | CC | 1192 | [10] | Targets of ETS1, identified by ChIP-chip in Jurkat T-cells. The microarray covered the promoter region from -5Kbp to 2Kbp of 17K genes. | ||||||||||||||||||||||||||
HCC-G1S_Whitfield | E2F | Ex | 266 | [27] | Genes whose expression peaks periodically in the G1/S cell cycle phase. | ||||||||||||||||||||||||||
HCC-G2M_Whitfield | NF-Y | Ex | 344 | [27] | Genes whose expression peaks periodically in the G2/M cell cycle phase. | ||||||||||||||||||||||||||
HNF1a_Odom | HNF1A | CC | 206 | [19] | Targets of HNF1α, identified by ChIP-chip in hepatocytes. The microarray covered the promoter region from -750bp to 250bp of 13K genes. | ||||||||||||||||||||||||||
HNF4a_Odom | HNF4A | CC | 1475 | [19] | Targets of HNF4α, identified by ChIP-chip in hepatocytes. The microarray covered the promoter region from -750bp to 250bp of 13K genes. | ||||||||||||||||||||||||||
HNF6_Odom | ONECUT | CC | 212 | [19] | Targets of HNF6, identified by ChIP-chip in hepatocytes. The microarray covered the promoter region from -750bp to 250bp of 13K genes. | ||||||||||||||||||||||||||
HSF1_Page | HSF1 | CC | 328 | [21] | Targets of HSF1, identified by ChIP-chip in HeLa cells under heat shock. The microarray covered the promoter region from -1.3Kbp to 200bp of 24K genes. | ||||||||||||||||||||||||||
ImmuneResponse_GO_Hs | IRF/NFKB | GO | 586 | [17] | GO Term; Accession - GO:0006955, Name - immune response, Ontology - biological process. In [17], IRF and NF-kB binding sites were found to be enriched in promoters of immune response genes. | ||||||||||||||||||||||||||
Nanog_Boyer | NANOG | CC | 714 | [3] | Targets of Nanog, identifed by ChIP-chip in embryonic stem cells. The microarray covered the promoter region from -8Kbp to 2Kbp of 18K genes. | ||||||||||||||||||||||||||
NFkB_Schreiber | NFKB | CC | 270 | [26] | Genes bound by one of the five NF-kB subunits in U937 cells before or 1 hour after lipopolysaccharide stimulation. The microarray covered the promoter region from -700bp to 200bp of 9,496 genes. | ||||||||||||||||||||||||||
Nrf1_Cam | NRF1 | CC | 674 | [5] | Targets of NRF1, identified by ChIP-chip in quiescent T98G cells. The microarray covered the promoter region from -700bp to 200bp of 13K genes. | ||||||||||||||||||||||||||
Oct4_Boyer | POU5F1 | CC | 241 | [3] | Targets of Oct4, identifed by ChIP-chip in embryonic stem cells. The microarray covered the promoter region from -8Kbp to 2Kbp of 18K genes. | ||||||||||||||||||||||||||
p53_Kannan | TP53 | Ex | 38 | [12] | Primary targets of p53: genes that were up-regulated under the induction of p53 and inhibition of protein synthesis by cycloheximide in H1299Val135 cells (lung cancer cell line that expresses the temperature sensitive murine p53). | ||||||||||||||||||||||||||
Sox2_Boyer | SOX2 | CC | 575 | [3] | Targets of Sox2, identifed by ChIP-chip in embryonic stem cells. The microarray covered the promoter region from -8Kbp to 2Kbp of 18K genes. | ||||||||||||||||||||||||||
SRF_Cooper | SRF | CC | 172 | [8] | Targets of SRF, identified by ChIP-chip in different cell lines: Jurkat, T/G HA-VSMC, and Be(2)-C cells. The microarray covered the promoter region from -1Kbp to 300bp of 19K genes. | ||||||||||||||||||||||||||
YY1_XiRen | YY1 | CC | 713 | [28] | Targets of YY1 identified by ChIP-chip. The microarray covered the promoter region from -1.3Kbp to 200bp of 24K genes. | ||||||||||||||||||||||||||
Foxp3_Marson | Mouse | Foxp3 | CC | 1060 | [18] | Targets of Foxp3, identified by ChIP-chip in Foxp3-CD4+ T-cell hybridomas that were transduced with FLAG-tagged Foxp3 and stimulated by phorbol myristate acetate/ionomycin. The microarray covered the promoter region from -8Kbp to 2Kbp of 16K genes. | |||||||||||||||||||||||||
ImmuneResponse_GO_Mm | Irf/Nfkb | GO | 329 | [17] | GO Term; Accession - GO:0006955, Name - immune response, Ontology - biological process. In [17], IRF and NF-kB binding sites were found to be enriched in promoters of immune response genes. | ||||||||||||||||||||||||||
MEF2_Blais | Mef2 | CC | 25 | [2] | Targets of Myocyte Enhancer Factor 2, identified by ChIP-chip in myotubes. The microarray covered the promoter region from -750bp to 250bp of 4700 genes. | ||||||||||||||||||||||||||
MyoD_Blais | Myod | CC | 102 | [2] | Targets of MyoD, identified by ChIP-chip in growing cells or myotubes. The microarray covered the promoter region from -750bp to 250bp of 4700 genes. | ||||||||||||||||||||||||||
MyoD_Cao | Myod | CC | 102 | [6] | Targets of MyoD. The ChIP-chip assay was performed in embryonic fibroblasts derived from mice that were double knockouts for Myod and Myf5, 36 hours after induction of differentiation. The microarray covered the promorer region from -750bp to 250bp of 13K genes. | ||||||||||||||||||||||||||
MyoG_Cao | Myog | CC | 78 | [6] | Targets of MyoG. The ChIP-chip assay was performed in embryonic fibroblasts derived from mice that were double knockouts for Myod and Myf5, 36 hours after induction of differentiation. The microarray covered the promorer region from -750bp to 250bp of 13K genes. | ||||||||||||||||||||||||||
Myogenin_Blais | Myog | CC | 106 | [2] | Targets of myogenin, identified by ChIP-chip on myotubes. The microarray covered the promoter region from -750bp to 250bp of 4700 genes. | ||||||||||||||||||||||||||
GATA_Pauli | C. elegans | GATA | Ex | 1342 | [22] | Genes that are expressed in the intestine. | |||||||||||||||||||||||||
HSF_Machin | Fly | Hsf | CC | 183 | [1] | Targets of heat-shock factor, identified by ChIP-chip in cells of embryos that were heat-shocked. The microarray contained full-length cDNA clones for 5000 genes. | |||||||||||||||||||||||||
MEF2_Sandmann | Mef2 | CC+Ex | 208 | [25] | High confidence targets of Mef2. The confidence was measured by a score that took into consideration the distance of the gene from the binding region, its expression in Mef2 mutant embryos and other supporting data. The Mef2 binding regions were identified by ChIP-chip with tiling array. | ||||||||||||||||||||||||||
MSL1_Legube | Dref | CC | 116 | [14] | Targets of male-specific lethal complex-1, identified by ChIP-chip on 0–14 h embryos or tightly staged 4–6 h embryos. The microarray covered 6000 clones. | ||||||||||||||||||||||||||
Myc_Oryan | Myc/Max/Mad | DamID | 714 | [20] | Targets of one or more of the proteins dMax, dMnt, and dMyc, identified by DamID assay on Kc cells. | ||||||||||||||||||||||||||
let7_Brueckner | Human | hsa-let-7a | Ex | 177 | [4] | Genes that were down-regulated in L7-A549 cells following let-7a-3 transfection. | |||||||||||||||||||||||||
let7_Johnson | hsa-let-7b | Ex | 182 | [11] | Genes that show altered expression in the presence of exogenously added let-7 in both HepG2 and A549 cells. | ||||||||||||||||||||||||||
miR1_Lim | hsa-miR-1 | Ex | 65 | [15] | Genes that were down-regulated in HeLa cells that were transfected with miR-1. | ||||||||||||||||||||||||||
miR16_Linsley | hsa-miR-16 | Ex | 90 | [16] | Genes that were down-regulated in HCT116 Dicerex5 and DLD-1 Dicerex5 cells that were transfected with miR-16. | ||||||||||||||||||||||||||
miR34_Chang | hsa-miR-34a | Ex | 89 | [7] | Genes that were down-regulated in HCT116 cells that were transfected with miR-34a. | ||||||||||||||||||||||||||
miR34_He | hsa-miR-34a | Ex | 367 | [9] | Genes that were down-regulated in HCT116 Dicerex5 cells that were transfected with miR-34a. | ||||||||||||||||||||||||||
miR106b_Linsley | hsa-miR-106b | Ex | 88 | [16] | Genes that were down-regulated in HCT116 Dicerex5 and DLD-1 Dicerex5 cells that were transfected with miR-106b. | ||||||||||||||||||||||||||
miR124_Lim | hsa-miR-124 | Ex | 116 | [15] | Genes that were down-regulated in HeLa cells that were transfected with miR-124. | ||||||||||||||||||||||||||
miR373_Lim | hsa-miR-373 | Ex | 43 | [15] | Genes that were down-regulated in HeLa cells that were transfected with miR-373. | ||||||||||||||||||||||||||
miR155_Rodriguez | Mouse | mmu-miR-155 | Ex | 95 | [24] | Genes that were up-regulated in CD4+ T cells of mice deficient for bic/miR-155. | |||||||||||||||||||||||||
References | |||||||||||||||||||||||||||||||
1. Birch-Machin I, Gao S, Huen D, McGirr R, White RA, Russell S: Genomic analysis of heat-shock factor targets in Drosophila. Genome Biol 2005, 6(7):R63. | |||||||||||||||||||||||||||||||
2. Blais A, Tsikitis M, Acosta-Alvear D, Sharan R, Kluger Y, Dynlacht BD: An initial blueprint for myogenic differentiation. Genes Dev 2005, 19(5):553-569. | |||||||||||||||||||||||||||||||
3. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG et al: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122(6):947-956. | |||||||||||||||||||||||||||||||
4. Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M, Sultmann H, Lyko F: The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 2007, 67(4):1419-1423. | |||||||||||||||||||||||||||||||
5. Cam H, Balciunaite E, Blais A, Spektor A, Scarpulla RC, Young R, Kluger Y, Dynlacht BD: A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell 2004, 16(3):399-411. | |||||||||||||||||||||||||||||||
6. Cao Y, Kumar RM, Penn BH, Berkes CA, Kooperberg C, Boyer LA, Young RA, Tapscott SJ: Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters. Embo J 2006, 25(3):502-511. | |||||||||||||||||||||||||||||||
7. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ et al: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007, 26(5):745-752. | |||||||||||||||||||||||||||||||
8. Cooper SJ, Trinklein ND, Nguyen L, Myers RM: Serum response factor binding sites differ in three human cell types. Genome Res 2007, 17(2):136-144. | |||||||||||||||||||||||||||||||
9. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D et al: A microRNA component of the p53 tumour suppressor network. Nature 2007, 447(7148):1130-1134. | |||||||||||||||||||||||||||||||
10. Hollenhorst PC, Shah AA, Hopkins C, Graves BJ: Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev 2007, 21(15):1882-1894. | |||||||||||||||||||||||||||||||
11. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J et al: The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007, 67(16):7713-7722. | |||||||||||||||||||||||||||||||
12. Kannan K, Amariglio N, Rechavi G, Jakob-Hirsch J, Kela I, Kaminski N, Getz G, Domany E, Givol D: DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 2001, 20(18):2225-2234. | |||||||||||||||||||||||||||||||
13. Kwon YS, Garcia-Bassets I, Hutt KR, Cheng CS, Jin M, Liu D, Benner C, Wang D, Ye Z, Bibikova M et al: Sensitive ChIP-DSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters. Proc Natl Acad Sci U S A 2007, 104(12):4852-4857. | |||||||||||||||||||||||||||||||
14. Legube G, McWeeney SK, Lercher MJ, Akhtar A: X-chromosome-wide profiling of MSL-1 distribution and dosage compensation in Drosophila. Genes Dev 2006, 20(7):871-883. | |||||||||||||||||||||||||||||||
15. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433(7027):769-773. | |||||||||||||||||||||||||||||||
16. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, Bartz SR, Johnson JM, Cummins JM, Raymond CK, Dai H et al: Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007, 27(6):2240-2252. | |||||||||||||||||||||||||||||||
17. Long F, Liu H, Hahn C, Sumazin P, Zhang MQ, Zilberstein A: Genome-wide prediction and analysis of function-specific transcription factor binding sites. In Silico Biol 2004, 4(4):395-410. | |||||||||||||||||||||||||||||||
18. Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, MacIsaac KD, Levine SS, Fraenkel E, von Boehmer H, Young RA: Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007, 445(7130):931-935. | |||||||||||||||||||||||||||||||
19. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK et al: Control of pancreas and liver gene expression by HNF transcription factors. Science 2004, 303(5662):1378-1381. | |||||||||||||||||||||||||||||||
20. Orian A, van Steensel B, Delrow J, Bussemaker HJ, Li L, Sawado T, Williams E, Loo LW, Cowley SM, Yost C et al: Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev 2003, 17(9):1101-1114. | |||||||||||||||||||||||||||||||
21. Page TJ, Sikder D, Yang L, Pluta L, Wolfinger RD, Kodadek T, Thomas RS: Genome-wide analysis of human HSF1 signaling reveals a transcriptional program linked to cellular adaptation and survival. Mol Biosyst 2006, 2(12):627-639. | |||||||||||||||||||||||||||||||
22. Pauli F, Liu Y, Kim YA, Chen PJ, Kim SK: Chromosomal clustering and GATA transcriptional regulation of intestine-expressed genes in C. elegans. Development 2006, 133(2):287-295. | |||||||||||||||||||||||||||||||
23. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD: E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 2002, 16(2):245-256. | |||||||||||||||||||||||||||||||
24. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA et al: Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316(5824):608-611. | |||||||||||||||||||||||||||||||
25. Sandmann T, Jensen LJ, Jakobsen JS, Karzynski MM, Eichenlaub MP, Bork P, Furlong EE: A temporal map of transcription factor activity: mef2 directly regulates target genes at all stages of muscle development. Dev Cell 2006, 10(6):797-807. | |||||||||||||||||||||||||||||||
26. Schreiber J, Jenner RG, Murray HL, Gerber GK, Gifford DK, Young RA: Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proc Natl Acad Sci U S A 2006, 103(15):5899-5904. | |||||||||||||||||||||||||||||||
27. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, Matese JC, Perou CM, Hurt MM, Brown PO et al: Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 2002, 13(6):1977-2000. | |||||||||||||||||||||||||||||||
28. Xi H, Yu Y, Fu Y, Foley J, Halees A, Weng Z: Analysis of overrepresented motifs in human core promoters reveals dual regulatory roles of YY1. Genome Res 2007, 17(6):798-806. | |||||||||||||||||||||||||||||||
29. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, Chen H, Jenner R, Herbolsheimer E, Jacobsen E et al: Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A 2005, 102(12):4459-4464. | |||||||||||||||||||||||||||||||